TScan Therapeutics
TCRX
#8994
Rank
HK$0.75 B
Marketcap
HK$12.41
Share price
0.00%
Change (1 day)
-79.36%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -HK$22.65

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$22.42. In 2022 the company made an earnings per share (EPS) of -HK$21.33 a decrease over its 2021 EPS that were of -HK$16.90.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$22.656.19%
2022-HK$21.3326.25%
2021-HK$16.9099.58%
2020-HK$8.47